Citalopram hydrobromide structure
|
Common Name | Citalopram hydrobromide | ||
---|---|---|---|---|
CAS Number | 59729-32-7 | Molecular Weight | 405.304 | |
Density | N/A | Boiling Point | 182-188ºC | |
Molecular Formula | C20H22BrFN2O | Melting Point | 182-188ºC | |
MSDS | Chinese USA | Flash Point | 212.8ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Citalopram hydrobromideCitalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression. |
Name | Citalopram Hydrobromide |
---|---|
Synonym | More Synonyms |
Description | Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has US FDA approval to treat major depression. |
---|---|
Related Catalog | |
References |
Boiling Point | 182-188ºC |
---|---|
Melting Point | 182-188ºC |
Molecular Formula | C20H22BrFN2O |
Molecular Weight | 405.304 |
Flash Point | 212.8ºC |
Exact Mass | 404.089935 |
PSA | 36.26000 |
LogP | 4.77108 |
Stability | Stable. Incompatible with strong oxidizing agents. |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
Hazard Codes | F,T |
Risk Phrases | 11-23/24/25-39/23/24/25 |
Safety Phrases | 7-16-36/37-45 |
RIDADR | UN 3249 |
RTECS | NP6313500 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2932999099 |
Precursor 10 | |
---|---|
DownStream 3 | |
HS Code | 2932999099 |
---|---|
Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Environmental friendly method for urban wastewater monitoring of micropollutants defined in the Directive 2013/39/EU and Decision 2015/495/EU.
J. Chromatogr. A. 1418 , 140-9, (2015) The fate and removal of organic micropollutants in the environment is a demanding issue evidenced by the recent European policy. This work presents an analytical method for the trace quantification of... |
|
Magnetic solid phase extraction coupled with desorption corona beam ionization-mass spectrometry for rapid analysis of antidepressants in human body fluids.
Analyst 140 , 5662-70, (2015) Ambient ionization techniques show good potential in rapid analysis of target compounds. However, a direct application of these ambient ionization techniques for the determination of analytes in a com... |
|
Salt effects in electromembrane extraction.
J. Chromatogr. A. 1347 , 1-7, (2014) Electromembrane extraction (EME) was performed on samples containing substantial amounts of NaCl to investigate how the presence of salts affected the recovery, repeatability, and membrane current in ... |
Lupram |
EINECS 261-890-6 |
Sepram |
Apertia |
Lu-10-171 |
1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide |
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide |
Citalopram hydrobromide |
Lu-10-171B |
1-isobenzofuranpropanaminium, 5-cyano-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-, bromide (1:1) |
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide (1:1) |
Elopram |
5-isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide |
1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile monohydrobromide |
Cipram |
MFCD02101306 |
Nitalapram |
Cipramil |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, hydrobromide (1:1) |
Seropram |
Celexa |
Lu 10-171-B |
1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide |
Prisdal |
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide |
Citalopram (hydrobromide) |